Topics

Dexcom CEO Kevin Sayer's comments at #JPM20 revealed apparent tension in the partnership between Verily and his San Diego-based diabetes-device company. https://buff.ly/2u7pLaA 

09:00 EST 16 Jan 2020 | STAT

Dexcom CEO Kevin Sayer's comments at revealed apparent tension in the partnership between Verily and his San Diego-based diabetes-device company. https://buff.ly/2u7pLaA 

Original Article: Dexcom CEO Kevin Sayer's comments at #JPM20 revealed apparent tension in the partnership between Verily and his San Diego-based diabetes-device company. https://buff.ly/2u7pLaA 

NEXT ARTICLE

More From BioPortfolio on "Dexcom CEO Kevin Sayer's comments at #JPM20 revealed apparent tension in the partnership between Verily and his San Diego-based diabetes-device company. https://buff.ly/2u7pLaA "

Quick Search

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...